| Drug Name |
Amlexanox |
| Drug ID |
BADD_D00120 |
| Description |
Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population. |
| Indications and Usage |
Used as a paste in the mouth to treat aphthous ulcers (canker sores). |
| Marketing Status |
Discontinued |
| ATC Code |
A01AD07; R03DX01 |
| DrugBank ID |
DB01025
|
| KEGG ID |
D01828
|
| MeSH ID |
C045742
|
| PubChem ID |
2161
|
| TTD Drug ID |
D0G5UB
|
| NDC Product Code |
71052-005; 73309-350; 72969-097 |
| Synonyms |
amlexanox | 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid | amoxanox | Aphthasol | CHX 3673 | AA 673 | AA-673 |
